5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.90▲ | 1.89▲ | 1.89▲ | 1.90▲ | 1.71▲ |
MA10 | 1.89▲ | 1.90▲ | 1.91▲ | 1.84▲ | 1.72▲ |
MA20 | 1.89▲ | 1.89▲ | 1.89▲ | 1.69▲ | 1.83▲ |
MA50 | 1.90▲ | 1.88▲ | 1.85▲ | 1.71▲ | 3.48▼ |
MA100 | 1.89▲ | 1.83▲ | 1.76▲ | 1.82▲ | 9.07▼ |
MA200 | 1.87▲ | 1.73▲ | 1.65▲ | 1.82▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.005▲ | -0.001▼ | -0.002▼ | 0.037▲ | 0.198▲ |
RSI | 58.375▲ | 56.025▲ | 57.632▲ | 69.099▲ | 41.162▼ |
STOCH | 85.931▲ | 45.172 | 62.507 | 94.360▲ | 50.889 |
WILL %R | -18.750▲ | -26.316 | -16.129▲ | -6.329▲ | -15.230▲ |
CCI | 164.994▲ | 43.645 | 65.625 | 92.367 | 77.330 |
Monday, April 21, 2025 05:00 PM
BOSTON, July 31, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced a ...
|
Tuesday, April 08, 2025 04:12 AM
The Nasdaq Composite (NASDAQINDEX: ^IXIC) is officially in a bear market. While it had been floating around in correction territory for a few weeks, it fell more than 20% below its all-time high ...
|
Friday, April 04, 2025 05:00 PM
HilleVax, Inc. (NASDAQ:HLVX – Get Free Report) has been given a consensus recommendation of “Hold” by the six analysts that are currently covering the company, MarketBeat.com reports.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 1.91 | 1.94 | 1.8302 | 1.93 | 319,318 |
30/04/25 | 1.89 | 1.955 | 1.79 | 1.94 | 444,520 |
29/04/25 | 1.865 | 1.95 | 1.855 | 1.92 | 513,257 |
28/04/25 | 1.84 | 1.89 | 1.8075 | 1.88 | 210,087 |
25/04/25 | 1.83 | 1.85 | 1.79 | 1.85 | 190,157 |
24/04/25 | 1.84 | 1.86 | 1.80 | 1.85 | 179,847 |
23/04/25 | 1.78 | 1.86 | 1.77 | 1.86 | 296,485 |
22/04/25 | 1.67 | 1.84 | 1.67 | 1.78 | 550,121 |
21/04/25 | 1.69 | 1.73 | 1.65 | 1.66 | 189,231 |
17/04/25 | 1.64 | 1.7232 | 1.64 | 1.69 | 115,106 |
|
|
||||
|
|
||||
|
|